This is the authors' abstract. We don't add key points for this paper.
As far as we know, this is the first meta-analysis evaluating the diagnosis and predictive value of blood NfL in MS. The present study indicates blood NfL may be a useful biomarker in diagnosing MS, distinguishing MS subtypes and predicting disease worsening in the future.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ning et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: